NCT01750840

Brief Summary

The purpose of this clinical registry is to capture data on an ongoing basis from a population of patients who will use Biomet's BHS, OrthoPak and SpinalPak devices.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 17, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

June 14, 2016

Completed
Last Updated

June 19, 2017

Status Verified

June 1, 2017

Enrollment Period

1 year

First QC Date

December 13, 2012

Results QC Date

March 9, 2016

Last Update Submit

June 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic Assessment of Healing

    Bone healing was assessed on x-rays and/or CT scan.

    The time frame for healing determination was not pre-specified. Patients were evaluated at regular doctors' visits for up to 12 months. The physician determined the time point at which healing occurred for each patient at their regular visits.

Secondary Outcomes (1)

  • Quality of Life Assessment

    The quality of life assessment was to be completed at the regular doctor's visit at which the physician determined the patient to be healed. No quality of life data was collected.

Study Arms (1)

Stimulation Group

All patients will receive either the Biomet® EBI Bone Healing System, Biomet OrthoPak® Non-invasive Bone Growth Stimulator System or Biomet SpinalPak® Non-Invasive Spine Fusion Stimulator Systems.

Device: Biomet® EBI Bone Healing SystemDevice: Biomet Orthopak® Non-Invasive Bone Growth Stimulator SystemDevice: Biomet SpinalPak® Non-Invasive Spine Fusion Stimulator

Interventions

A pulsed electromagnetic fields electrical stimulation device used for the treatment of fracture nonunions. Designed to be used for 3-10 hours per day with a recommended use of 10 hours per day.

Stimulation Group

A capacitive coupling electrical stimulation device used for the treatment of fracture nonunions. Designed to be used for 24 hours per day.

Stimulation Group

A capacitive coupling electrical stimulation device used as an adjunctive treatment to lumbar spinal fusion. Designed to be used for 24 hours per day.

Stimulation Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This clinical registry will be a prospective, multi-center study. Subjects will undergo treatment with Biomet's BHS or OrthoPak devices for non-spinal applications. Subjects will undergo treatment with Biomet's SpinalPak for spinal applications

You may qualify if:

  • Subject has agreed to undergo electrical stimulation therapy as prescribed by their physician.
  • Subject has agreed to return to the physician for their physician required follow up visits.
  • Subject will undergo treatment with Biomet's BHS, OrthoPak or SpinalPak devices.
  • Subject has agreed to complete QoL questionnaires prior to starting treatment and at the follow up visit when the physician has determined the subject to be either healed or failed.

You may not qualify if:

  • Any subject not willing to comply with the physician prescribed treatment program and follow up visit schedule.
  • Any subject not willing to complete the QoL questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cumberland Orthopedics

Vineland, New Jersey, 08360, United States

Location

MeSH Terms

Conditions

DiseaseFractures, Ununited

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsFractures, BoneWounds and Injuries

Results Point of Contact

Title
Manager of Research
Organization
Biomet

Study Officials

  • Randy Graham

    Zimmer Biomet

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2012

First Posted

December 17, 2012

Study Start

October 1, 2012

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

June 19, 2017

Results First Posted

June 14, 2016

Record last verified: 2017-06

Locations